Morria Biopharmaceuticals
Celsus Therapeutics is a drug development company focusing on novel anti-inflammatory;first-in-class synthetic drugs.
Morria Biopharmaceuticals has raised €13M across 3 funding rounds, most recently a round in Oct 2013. Based in London, UK; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€13M
€13,440,600
Funding rounds
3
Investors
0
distinct backers
Active since
2012-12
latest 2013-10
Funding by year
EUR raised per yearMorria Biopharmaceuticals — funding by year — interactive chart.
Data table
| Morria Biopharmaceuticals — funding by year | |
|---|---|
| 2012 | €1.4M |
| 2013 | €12M |
Signals
Medium confidenceRaise-next likelihood7
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood6
base rate 11% (2+ rounds)
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2013-10-01 | Other | €11M | — | View deal → |
| 2013-02-01 | Other | €838k | — | View deal → |
| 2012-12-01 | Other | €1.4M | — | View deal → |